Warning letter
Prime Health Products: warning letter of Jul 29, 2015
FDA warning letter 454614 · Center for Food Safety and Applied Nutrition
Key facts
| Reference number | 454614 |
|---|---|
| Company | Prime Health Products |
| Subject | Unapproved New Drug/Misbranding/Adulterated |
| Issue date | Jul 29, 2015 |
| Posted date | Aug 18, 2015 |
| Issuing office | Center for Food Safety and Applied Nutrition |
| Product type | Food/Cosmetics |
| CFR sections cited | 101, 101.36, 111, 111.255, 111.260, 101.4(h)(1), 111.70(b)(2), 111.70(e), 111.210(h)(2), 111.260(j)(2)(iv), 111.75(c), 701.13(b) |
| Inspection city | Etobicoke |
| Inspection start date | Sep 8, 2014 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: